MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development work on "Industrial Scale Technology for Drug Development in Mature Human Fat Cells. The company's innovative approach promises to improve patient outcomes by tapping into the therapeutic potential of mature human fat cells.